ID   C-B9538F
AC   CVCL_LM94
SY   C-B95; TNGB-65823; 65823
DR   CLO; CLO_0002212
DR   CLDB; cl523
DR   TNGB; 65823
DR   Wikidata; Q54799756
RX   PubMed=17668376;
CC   From: Galliera Genetic Bank, E.O. Ospedali Galliera; Genova; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18-22FW
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
RX   PubMed=17668376; DOI=10.1086/519248; PMCID=PMC1950802;
RA   Prandini P., Deutsch S., Lyle R., Gagnebin M., Delucinge-Vivier C.,
RA   Delorenzi M., Gehrig C., Descombes P., Sherman S.L.,
RA   Dagna-Bricarelli F., Baldo C., Novelli A., Dallapiccola B.,
RA   Antonarakis S.E.;
RT   "Natural gene-expression variation in Down syndrome modulates the
RT   outcome of gene-dosage imbalance.";
RL   Am. J. Hum. Genet. 81:252-263(2007).
//